ArticleBlood cancer journal2026

Correction: Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients.

Hira Cheema et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.